Cytokinetics (CYTK)
45.10 -0.90 (-1.96%) 09:51 ET [NASDAQ]
45.38 x 200 45.55 x 300
Realtime by (Cboe BZX)
45.38 x 200 45.55 x 300
Realtime 45.50 -0.50 (-1.09%) 06:50 ET
for Mon, Mar 3rd, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -589,526 | -526,244 | -388,955 | -215,314 | -127,290 |
| Depreciation Amortization | 9,531 | 11,892 | 5,814 | 2,276 | 1,831 |
| Accounts receivable | -15,367 | -1,136 | 56,672 | -47,399 | 743 |
| Accounts payable and accrued liabilities | -4,483 | -3,483 | 4,524 | 1,055 | -110 |
| Other Working Capital | 35,664 | 3,089 | -24,704 | 8,456 | 84,896 |
| Other Operating Activity | 168,291 | 101,549 | 47,133 | 108,404 | 48,873 |
| Operating Cash Flow | $-395,890 | $-414,333 | $-299,516 | $-142,522 | $8,943 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,906 | -1,416 | -11,335 | -48,872 | -11,052 |
| Purchase Of Investment | -1,293,416 | -635,211 | -855,393 | -525,042 | -435,825 |
| Sale Of Investment | 744,225 | 875,880 | 604,594 | 426,137 | 250,362 |
| Investing Cash Flow | $-553,097 | $239,253 | $-262,134 | $-147,777 | $-196,515 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 523,586 | N/A | N/A |
| Debt Repayment | -9,618 | -858 | -188,925 | N/A | 0 |
| Common Stock Issued | 93,640 | 164,233 | N/A | 309,285 | 198,003 |
| Other Financing Activity | 846,589 | 57,942 | 181,505 | 10,695 | 36,121 |
| Financing Cash Flow | $930,611 | $221,317 | $516,166 | $319,980 | $234,124 |
| Exchange Rate Effect | 209 | -20 | N/A | N/A | N/A |
| Beginning Cash Position | 113,399 | 67,182 | 112,666 | 82,985 | 36,433 |
| End Cash Position | 95,232 | 113,399 | 67,182 | 112,666 | 82,985 |
| Net Cash Flow | $-18,167 | $46,217 | $-45,484 | $29,681 | $46,552 |
| Free Cash Flow | |||||
| Operating Cash Flow | -395,890 | -414,333 | -299,516 | -142,522 | 8,943 |
| Capital Expenditure | -3,906 | -1,416 | -11,335 | -48,872 | -11,052 |
| Free Cash Flow | -399,796 | -415,749 | -310,851 | -191,394 | -2,109 |